Nirvana10 mg

Nirvana 10 mg is a long-acting PDE5 inhibitor prescribed for men to manage several urological and sexual health conditions. It is clinically indicated for the treatment of:

• Erectile Dysfunction (ED): Helps men achieve and maintain an erection sufficient for satisfactory sexual activity.
• Benign Prostatic Hyperplasia (BPH): Relieves the bothersome urinary symptoms associated with an enlarged prostate, such as weak stream, urgency and frequent urination.
• Combined ED and BPH: Effectively treats both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia in men who have both conditions at the same time.

Because of its extended duration of action of up to 36 hours, Nirvana 10 mg is often preferred for greater spontaneity compared with shorter-acting alternatives. It should always be taken under the guidance of a registered physician.

Drugs for Erectile Dysfunction

Nirvana 10 mg is a selective inhibitor of the enzyme phosphodiesterase type 5 (PDE5). Its therapeutic effects are driven by its influence on cyclic guanosine monophosphate (cGMP), a key signalling molecule that controls smooth muscle tone and blood flow.

During sexual stimulation, nitric oxide is released, which activates the production of cGMP in the smooth muscle cells of the penis. By blocking PDE5, Nirvana 10 mg prevents the breakdown of cGMP, allowing it to accumulate. Elevated cGMP causes relaxation of smooth muscle in the corpus cavernosum and increases blood flow, resulting in a firmer and more sustained penile erection.

PDE5 is also found in the smooth muscle of the prostate gland and bladder wall. Inhibition of PDE5 in these tissues raises cGMP levels, relaxing the smooth muscle of the prostate and bladder neck. This improves blood flow to the lower urinary tract and widens the bladder outlet, easing urine flow and reducing the urinary symptoms linked to benign prostatic hyperplasia.

Nirvana 10 mg is distinguished by its slow elimination and long half-life, which is responsible for its characteristic prolonged duration of action of up to 36 hours.

Nirvana 10 mg can interact with several medicines, foods and substances, which may increase the risk of side effects or reduce its effectiveness. Notable interactions include:

• Nitrates (e.g., Isosorbide, Nitroglycerin): Concurrent use can cause a dangerous drop in blood pressure and is contraindicated.
• Alpha-adrenergic blockers and other antihypertensive drugs: May enhance the blood-pressure-lowering effect, leading to dizziness or fainting.
• Alcohol: Can add to the hypotensive effect and increase the risk of light-headedness.
• Antacids (magnesium hydroxide/aluminium hydroxide): May affect the rate of Nirvana 10 mg absorption.
• CYP3A4 inhibitors (Ketoconazole, Itraconazole, Erythromycin, Ritonavir and other HIV protease inhibitors): May raise Nirvana 10 mg levels in the blood.
• CYP3A4 inducers (Rifampin, Carbamazepine, Phenytoin, Phenobarbital): May lower Nirvana 10 mg levels and reduce its effect.
• Grapefruit juice: May increase Nirvana 10 mg blood concentrations.

Inform your physician of all prescription drugs, over-the-counter medicines and supplements you use before starting Nirvana 10 mg.

Most side effects of Nirvana 10 mg are mild to moderate and often ease as the body adjusts. Common side effects include:

• Headache
• Dyspepsia (indigestion)
• Back pain
• Myalgia (muscle pain)
• Nasopharyngitis (inflammation of the nose and throat)
• Nasal congestion

Rare but serious side effects that require immediate medical attention include:

• Change in colour vision or sudden loss of vision
• Sudden hearing loss
• Stevens-Johnson Syndrome and exfoliative dermatitis (severe skin reactions)
• Angina, myocardial infarction (heart attack) or stroke
• Severe hypotension (very low blood pressure) or tachycardia (rapid heartbeat)

Seek urgent medical help if an erection lasts longer than 4 hours (priapism) or if any severe reaction occurs.

Pregnancy: Nirvana 10 mg has been assigned to Pregnancy Category B by the US FDA. It is recommended for use during pregnancy only when the potential benefit clearly outweighs the potential risk. As Nirvana 10 mg is intended for use in men, this consideration primarily applies to any inadvertent use in women.

Lactation: There are no data on the excretion of Nirvana 10 mg in human breast milk. Caution should therefore be exercised if Nirvana 10 mg is administered to a nursing woman.

Careful evaluation and monitoring are advised in patients with certain underlying conditions or concurrent treatments. Precautions should be taken in patients with:

• Angina or known cardiovascular disease
• Renal (kidney) impairment
• Hepatic (liver) impairment
• Increased risk of bleeding

Extra caution is also needed when Nirvana 10 mg is used together with:

• Nitrates
• Alpha blockers
• Alcohol
• CYP3A4 inhibitors (e.g., Ritonavir, Ketoconazole, Itraconazole)
• Other PDE5 inhibitors

Patients should consult their physician before combining Nirvana 10 mg with any of these agents.

Store Nirvana 10 mg in a dry place, protected from light and heat. Keep the medicine out of the reach of children and pets. Do not use after the expiry date printed on the package.

Drugs for Erectile Dysfunction

Nirvana 10 mg is a selective phosphodiesterase type 5 (PDE5) inhibitor. Inhibition of PDE5 increases cGMP in smooth muscle cells. cGMP causes smooth muscle relaxation and increased blood flow into the corpus cavernosum, causing penile erection. PDE5 also is present in smooth muscles of the prostate and bladder wall. Inhibiting PDE5 increases cGMP concentrations leading to relaxation of smooth muscle in the prostate and bladder. Smooth muscle relaxation may improve blood flow to the urinary tract and widen the opening of the bladder neck, resulting in improved voiding.

Nirvana 10 mg has been assigned to pregnancy category B by the USFDA. Nirvana 10 mg is only recommended for use during pregnancy when benefit outweighs risk. There are no data on the excretion of Nirvana 10 mg in human milk. Caution should be used when administering Nirvana 10 mg to nursing women.